scholarly journals P2-259 Cancer risk in children with birth defects: a longitudinal, population-based assessment among 2.7 million births

2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A293-A293
Author(s):  
P. A. Romitti ◽  
T. Flood ◽  
M. L. Feldkamp ◽  
S. Krikov ◽  
S. Puzhankara ◽  
...  
2018 ◽  
Author(s):  
Jeremy M. Schraw ◽  
Tania A. Desrosiers ◽  
Wendy N. Nembhard ◽  
Glenn Copeland ◽  
Robert E. Meyer ◽  
...  

JAMA Oncology ◽  
2019 ◽  
Vol 5 (8) ◽  
pp. 1150 ◽  
Author(s):  
Philip J. Lupo ◽  
Jeremy M. Schraw ◽  
Tania A. Desrosiers ◽  
Wendy N. Nembhard ◽  
Peter H. Langlois ◽  
...  

BMJ ◽  
2020 ◽  
pp. m4060
Author(s):  
Dagrun Slettebø Daltveit ◽  
Kari Klungsøyr ◽  
Anders Engeland ◽  
Anders Ekbom ◽  
Mika Gissler ◽  
...  

AbstractObjectiveTo examine associations between birth defects and cancer from birth into adulthood.DesignPopulation based nested case-control study.SettingNationwide health registries in Denmark, Finland, Norway, and Sweden.Participants62 295 cancer cases (0-46 years) and 724 542 frequency matched controls (matched on country and birth year), born between 1967 and 2014.Main outcome measuresRelative risk of cancer in relation to major birth defects, estimated as odds ratios with 99% confidence intervals from logistic regression models.ResultsAltogether, 3.5% (2160/62 295) of cases and 2.2% (15 826/724 542) of controls were born with major birth defects. The odds ratio of cancer for people with major birth defects compared with those without was 1.74 (99% confidence interval 1.63 to 1.84). For individuals with non-chromosomal birth defects, the odds ratio of cancer was 1.54 (1.44 to 1.64); for those with chromosomal anomalies, the odds ratio was 5.53 (4.67 to 6.54). Many structural birth defects were associated with later cancer in the same organ system or anatomical location, such as defects of the eye, nervous system, and urinary organs. The odds ratio of cancer increased with number of defects and decreased with age, for both non-chromosomal and chromosomal anomalies. The odds ratio of cancer in people with any non-chromosomal birth defect was lower in adults (≥20 years: 1.21, 1.09 to 1.33) than in adolescents (15-19 years: 1.58, 1.31 to 1.90) and children (0-14 years: 2.03, 1.85 to 2.23). The relative overall cancer risk among adults with chromosomal anomalies was markedly reduced from 11.3 (9.35 to 13.8) in children to 1.50 (1.01 to 2.24). Among adults, skeletal dysplasia (odds ratio 3.54, 1.54 to 8.15), nervous system defects (1.76, 1.16 to 2.65), chromosomal anomalies (1.50, 1.01 to 2.24), genital organs defects (1.43, 1.14 to 1.78), and congenital heart defects (1.28, 1.02 to 1.59) were associated with overall cancer risk.ConclusionsThe increased risk of cancer in individuals with birth defects persisted into adulthood, both for non-chromosomal and chromosomal anomalies. Further studies on the molecular mechanisms involved are warranted.


2021 ◽  
Vol 76 (4) ◽  
pp. 191-193
Author(s):  
Dagrun Slettebø Daltveit ◽  
Kari Klungsøyr ◽  
Anders Engeland ◽  
Anders Ekbom ◽  
Mika Gissler ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e69077 ◽  
Author(s):  
Lorenzo D. Botto ◽  
Timothy Flood ◽  
Julian Little ◽  
Mark N. Fluchel ◽  
Sergey Krikov ◽  
...  

The Prostate ◽  
2021 ◽  
Author(s):  
Jun Wei ◽  
Wancai Yang ◽  
Zhuqing Shi ◽  
Lucy Lu ◽  
Qiang Wang ◽  
...  

Author(s):  
Sonia Guleria ◽  
Allan Jensen ◽  
Vanna Albieri ◽  
Bugge Nøhr ◽  
Kirsten Frederiksen ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ying-Yi Lu ◽  
Hung-Pin Tu ◽  
Chieh-Hsin Wu ◽  
Chien-Hui Hong ◽  
Kuo-Chia Yang ◽  
...  

AbstractKeloid is a skin disease characterized by exaggerated scar formation, excessive fibroblast proliferation, and excessive collagen deposition. Cancers commonly arise from a fibrotic microenvironment; e.g., hepatoma arises from liver cirrhosis, and oral cancers arise from submucosal fibrosis. As keloids are a prototypic fibroproliferative disease, this study investigated whether patients with keloids have an increased cancer risk. In a matched, population-based study, first 17,401 patients treated for keloids during 1998–2010 with 69,604 controls without keloids at a ratio of 1:4 were evaluated. The association between keloids and risk of cancer was estimated by logistic regression or Cox proportional hazard regression models after adjustment of covariates. In total, 893 first-time cases of cancer were identified in the 17,401 patients with keloids. The overall cancer risk was 1.49-fold higher in the keloids group compared to controls. Regarding specific cancers, the keloids group, had a significantly higher risk of skin cancer compared to controls (Relative risk = 1.73). The relative risk for skin cancer was even higher for males with keloids (Relative risk = 2.16). Further stratified analyses also revealed a significantly higher risk of developing pancreatic cancer in female patients with keloids compared to controls (Relative risk = 2.19) after adjustment for known pancreatic cancer risk factors. This study indicates that patients with keloids have a higher than normal risk for several cancer types, especially skin cancers (both genders) and pancreatic cancer (females). Therefore, patients with keloids should undergo regular skin examinations, and females with keloids should regularly undergo abdominal ultrasonography.


Sign in / Sign up

Export Citation Format

Share Document